cliexa is excited to announce that we have been nominated by the Denver Metro Chamber of Commerce (DMCC) as one of the three finalists for Start-Up of the Year! Each year, the DMCC recognizes businesses in the Denver area for their exceptional work in providing great jobs and helping to shape the local business community.

 

Here at cliexa, we pride ourselves on our innovation and competitiveness among leading digital healthcare organizations. Being recognized by local business leaders as an integral part of Denver’s start-up community has us reeling with excitement. We are excited to attend the DMCC’s 2020 Business Awards on April 24th, and you can register here for the luncheon to come cheer us on!

 

The DMCC 2020 Business Awards finalists include:

  • Disruptor of the Year: AT&T, RK, and Teatulia Organic Teas
  • Minority or Women-owned Business of the Year: Aim High Chiropractic, Novitas Communications, and Workplace Resource
  • Small Business of the Year: Bespoke Event Group, Core Contractors, Roofing Systems, and YellowDog Denver
  • Start-Up of the Year: cliexa, Emerge Professional Services, and Urban Solution Group
  • Small Nonprofit of the Year: Heart & Hand Center, Project Helping, and WeeCycle
  • Large Nonprofit of the Year: Denver Scholarship Foundation, Habitat for Humanity of Metro Denver, and Metro Caring

We would like to thank the Denver Metro Chamber of Commerce and presenting sponsor BOK Financial for recognizing these finalists and highlighting 18 of Denver’s finest business leaders and innovators.

 

Today we welcomed representatives from DMCC, the Denver community, and executives from last year’s business awards to our office. During this visit, cliexa employees had the opportunity to show off their hard work and reflect on their successes while answering questions from the judges.

 

cliexa’s CEO & Founder, Mehmet, showing DMCC judges the innovative cliexa platform

 

Start-Up Business of the Year finalists include cliexa, Emerge Professional Services, and Urban Solution Group. Emerge Professional Services provides talent and retention solutions in their approach to staffing and raising talent levels in an organization. Urban Solution Group provides mitigation plans for oil and gas development through their collaboration with operators and communities. Learn more about the finalists for the DMCC 2020 Business Awards here.

cliexa's Patent Allowance for Evidence-Based Clinical Data Collection & Processing

Today, we are proud to announce that the United States Patent and Trademark Office has announced the issuance of U.S Patent Number 14,243,549 for cliexa’s “System and Methods for Disease Management.” This patent covers clinical data collection and processing using an “Evidence-Based Data Indexing” (EBDI) model which is the core function of cliexa’s modular digital intake and remote monitoring platform. cliexa enables clinicians to monitor patients’ disease activities and clinical outcomes based on standard and dynamic thresholds within treatment workflows. The platform is tailored by subspecialties and provides automated compliance and billing outputs through cliexa’s proprietary integration services engine.

Disease activity is collected digitally through clinically-validated assessments and stored in a discrete format. This data indexing is generated by a proprietary algorithm referencing connected device data, claims data, and medication adherence or complications. Dynamic stored procedures use a new algorithm every time to update the patient-reported outcome assessments in the database and the application server would process the new or multiple assessments to be enabled in mobile front-end to collect data differently to be able to predict risk factors for specific demographics and multiple chronic disease states. Our computing objects get smarter using a learning algorithm by not only comparing the multiple disease data but also the treatment responses from patients and dynamically changing treatments by their clinicians.

Patients are also presented this dynamic data (e.g. what status their disease at compared to millions of other patients with two or more chronic conditions) to become self-advocates of their care and included IoT data also feeds back to the storage service with smart computing objects to compare existing patient data with others already in the system to give an informed picture to the clinicians.

“We are extremely excited to start 2020 with this recognition by the U.S. Patent Office. As clinical data collection and analysis become more powerful every day for the healthcare industry, cliexa’s model leverages proprietary learning algorithms and AI infrastructure, managing multiple conditions by connecting patients to their providers more effectively,” said Mehmet Kazgan, Founder & CEO of cliexa.

cliexa announces new partnership with Colorado Clinic on innovative solution for interventional, chronic pain management
cliexa announces new partnership with Colorado Clinic on innovative solution for interventional, chronic pain management

We are thrilled to announce we have teamed up with Colorado Clinic to redefine their data collection and documentation process using the cliexa platform. Colorado Clinic is a leader in combatting the opioid crisis by offering cutting-edge, non-narcotic solutions for holistic interventional pain management. The cliexa platform enables patients and physicians to track disease activity and leverage proprietary technology that makes intelligent correlations between medication dosage, frequency, and heightened or reduced symptoms. Together, we partner to offer an innovative solution for chronic pain management with the cliexa-EASE platform.

With the cliexa-EASE platform, Colorado Clinic patients will be able to digitally complete the entire intake process upon arrival to the clinic. This digitized process includes consent documentation, chief complaints, and screener questions such as the Screener and Opioid Assessment for Patients in Pain (SOAPP-14) to monitor at-risk patients. The SOAPP model is a 14-item, self-report measure designed to address the appropriateness of therapy for chronic pain patients.

Clinicians will receive a full report delivered directly into their athenahealth electronic medical record (EMR) system with auto-generated treatment recommendations determined by the Colorado Clinic staff for each individual patient. 

cliexa has also developed a proprietary risk stratification model for Colorado Clinic to determine the level of risk for patients taking opiates. Based on the calculated risk level, urine analysis frequency recommendations will be generated in the clinician report in accordance with Colorado Clinic’s clinical guidelines report.

Through cliexa’s computer adaptive testing system and individual patient matching, patients will be able to complete standardized assessments that are triggered by the chief complaints and responses in the SOAPP-14 assessment. This method allows Colorado Clinic to deliver a highly personalized patient experience. cliexa empowers providers with compliance algorithms built-in to the platform, enabling them to see billing recommendations based on the patient inputs, allowing them to gather accurate reimbursement metrics to sync with the MIPS quality report.

With this collaboration, the cliexa-EASE platform will be available soon at all 5 of Colorado Clinic’s locations including Aurora, Colorado Springs, Greeley, Loveland, and Thornton. We can not be more excited to collaborate with the team at Colorado Clinic, and we look forward to providing more content about the project in the coming months.

Is your practice using the athenahealth EMR and want to learn more about how to enable cliexa? Check out our quick, 5-step setup guide!

Researchers Receive $1 Million Grant to Study Digital Screening Intervention Tool for Adolescents and Young Adults

cliexa is excited to partner with the University of Northern Colorado (UNC) with a grant from the Department of Health and Human Services’ Office of Adolescent Health that provides nearly one million dollars over the next two years for the implementation of cliexa-OPTIONS, a digital screening intervention tool that fosters earlier identification of high-risk adolescents in a clinical setting. The funding supports independent evaluation including, cost-benefit analysis and randomized controlled trial of the cliexa-OPTIONS risk screening tool and MyPLAN mobile health follow-up. The Principal Investigator for the project at UNC is Dr. William Merchant. He is the evaluation professor in the Applied Statistics and Research Methods program in the College of Education and Behavioral Sciences. 

The cost-benefit analysis assesses cost savings between the cliexa-OPTIONS risk screening against current paper pencil and verbal screenings. Also, the cliexa-OPTIONS risk screening identifies 30- 50% more risk in adolescent populations fostering early identification of adolescents at highest risk for acquiring an STI or experiencing an unplanned pregnancy. Improving quality in clinical workflows for adolescent and young adult populations is timely, given that sexually transmitted infections for young people ages 15 -24 are at epidemic proportions.

Saving time and keeping providers satisfied with new technology in clinical workflows is no simple task. The cost-benefit analysis will also assess the benefits of early identification of adolescents at highest risk for adverse reproductive health outcomes, substance use, mental health, and wellness.

Read the full article at: //www.unco.edu/news/newsroom/releases/million-dollar-grant-digital-screening-intervention-tool.aspx

cliexa is now available in the athenaHealth Marketplace

Today, cliexa Inc., a thriving producer of mobile health care management services, revealed a partnership with athenahealth, Inc.® through athenahealth’s “More Disruption Please” (MDP) Marketplace program. As an MDP partner, our cross-communication platform developed for chronic pain patients and providers, cliexa-EASE, is now immediately available to athenahealth’s network of 100,000+ providers and countless prospective clients. EASE enables patients and clinicians to make intelligent correlations between medication dosage, frequency and heightened or reduced symptoms by leveraging an application that functions as a pain assessment model for chronic pain management with seamless scalable EMR integration via API and global HL7 connectivity.

cliexa provides the ideal pain management application to leverage patient-reported outcomes to improve treatment decisions and patient experience, while also maximizing compliance and reimbursement. cliexa-EASE is designed for chronic pain management, podiatry, and general patient wellness. cliexa-EASE allows providers to gather digitized intake data and customize assessments to correlate data that best adheres to their patient population.

In order to provide physicians with high accuracy metrics, cliexa-EASE uses patient reporting methods on visual body maps, and pain expression in voice, face, and body movements. This allows physicians to view the physical attributes of pain beyond self-reported descriptions which can often be difficult to translate into clinical diagnostics terms. Tracking these markers allows physicians to use patient-reported outcomes to treat the “whole patient.”  One of cliexa’s existing clients, Anderson Podiatry Center, is already seeing the benefits of using the cliexa platform with a custom digital patient intake and screening process, also digital consent forms, integrated to their athenahealth electronic medical record (EMR).

The athenahealth Marketplace partnership opens up a hyperconnected, national network of healthcare professionals providing chronic pain management. With this partnership, the two companies align to provide measurable financial and clinical results for providers. cliexa is a real-time data provider for future medicine and will continue to build on our vision to increase patient-provider engagement and compliance through mobile health solutions.

“We are excited to partner both with athenahealth and Anderson Podiatry Center to deploy cliexa platform into the marketplace as this is the first of many subspecialties we currently have in our portfolio. We are looking forward to implementing other subspecialty applications to the athenahealth marketplace which will strengthen our partnership in healthcare space,” says Mehmet Kazgan, Founder and CEO of cliexa.

Eric Seyler, CEO of Anderson Podiatry Center, says, “The transition to a digital patient intake has given us more opportunities to help our patients than we had envisioned. Our patients have spent less time in the waiting room with more time delegated to their doctor’s visit. The integration is done in real-time which supports our goal to be more efficient with clinic resources while helping to provide the best possible patient experience.”

cliexa enables patients to track their chronic disease activity by quantifying symptoms using scientifically-proven and clinically-validated scoring models. cliexa delivers quantified disease activity and documentation through real-time integration to athenahealth electronic medical record, which streamlines processes and increases efficiency in population health management.

View our listing here: //marketplace.athenahealth.com/product/cliexa